...
首页> 外文期刊>Liver international : >Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma.
【24h】

Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma.

机译:小肝癌根治性切除术后晚期复发的预测因素。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The tumour recurrence rate after resection is still high even in patients with small hepatocellular carcinoma (HCC). The advanced patterns of recurrence occasionally occur after resection. In this study, we analysed the clinical and histological characteristics of small HCC and evaluated the predictive factors of advanced tumour recurrence. METHODS: One hundred and sixty-five patients underwent resection of small HCC measuring 3 cm or less in greatest dimension. Patterns of tumour recurrences were classified into advanced recurrence and minor recurrence based on size, number, vascular invasion and extrahepatic metastasis of recurrent tumour. We created a simple index to closely evaluate the malignant potential of small HCC, named alpha-foetoprotein-size ratio index (ASRI). RESULTS: Overall tumour recurrence was significantly associated with tumour multiplicity (P<0.001) and ASRI (P=0.001). Tumour multiplicity, ASRI and tumour differentiation were independent and significant predictive factors of advanced recurrences. The overall survival rates were lower in the advanced recurrence group than the minor recurrence or the no recurrence group. CONCLUSIONS: Patients with advanced recurrences have a poor prognosis, although they have undergone curative resection of small HCC. On the other hand, patients with minor recurrences have a relatively good prognosis. ASRI was a useful index to predict advanced recurrence after curative resection of small HCC. The therapeutic management to prevent advanced recurrences is needed.
机译:背景:即使在小肝细胞癌(HCC)患者中,切除后的肿瘤复发率仍然很高。切除后偶尔会发生晚期复发。在这项研究中,我们分析了小肝癌的临床和组织学特征,并评估了晚期肿瘤复发的预测因素。方法:165例患者接受了最大尺寸为3 cm或更小的小型HCC切除术。根据复发肿瘤的大小,数量,血管浸润和肝外转移,将肿瘤复发的模式分为晚期复发和轻度复发。我们创建了一个简单的指数来密切评估小型HCC的恶性潜能,即α-甲胎蛋白大小比率指数(ASRI)。结果:总体肿瘤复发与肿瘤的多发性(P <0.001)和ASRI(P = 0.001)显着相关。肿瘤多样性,ASRI和肿瘤分化是晚期复发的独立且重要的预测因素。晚期复发组的总生存率低于轻度复发组或无复发组。结论:晚期复发患者尽管接受了小肝癌的根治性切除,但预后较差。另一方面,复发较小的患者预后相对较好。 ASRI是预测小肝癌根治性切除术后晚期复发的有用指标。需要预防晚期复发的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号